Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10
Biohit Oyj
STOCK EXCHANGE RELEASE
June 8, 2018 at 3.40 PM
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
Biohit Oyj has received an announcement from Osmo Suovaniemi on June 8, 2018 in accordance with the Finnish Securities Market Act Chapter 9, Section 5.
According to the announcement, the total number of Biohit Oyj shares owned by Osmo Suovaniemi has decreased below fifteen (15) per cent of the share capital of Biohit Oyj on June 8, 2018.
Total positions of Osmo Suovaniemi according to the notification:
| % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both in % | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which the threshold was crossed or reached | 13,56 % shares and 56,52 % votes | 14 889 278 shares and 71 423 778 votes | ||
| Position of previous notification (if applicable) | 34,76 % shares and 68,43 5 votes |
Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: shares and voting rights:
| Class / type of shares ISIN-code | Number of shares and voting rights | % of shares and voting rights | ||||
| Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 ja 9:7) | |||
| FI0009005482 | 0 | 0 | 0 | % | 0 | % |
| A-shares | 2 018 310 shares and 40 366 200 votes | 13,56 % shares and 56,52 % votes | ||||
| SUBTOTAL A | 2 018 310 shares and 40 366 200 votes | 13,56 % shares and 56,52 % votes | ||||
B: Financial instruments according to SMA 9:6a
| Type of Financial instrument | Expiration date | Exercise / Conversion period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
| SUBTOTAL B | |||||
Information on the party obliged to give notice of major shareholding:
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:
| Name | % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both |
| Osmo Suovaniemi | 13,56 % shares and 56,52 % votes | 2 018 310 shares and 40 366 200 votes | |
| Interlab Oy | 0 | 0 |
More information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi, www.biohit .fi
Biohit Oyj in brief
Biohit Oyj is a Finnish biotechnology company operating on a global scale. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit’s headquarters are located in Helsinki with subsidiaries in Italy and the UK.